Iqbal, Javaid <br/><br/>
DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial.  [electronic resource] 

 -  EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology  Dec 2016 
 - e1336-e1342 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1969-6213 
<br/><br/><label>Standard No.: </label>10.4244/EIJY15M10_04  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Coronary Disease--therapy<br/>Drug-Eluting Stents<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Macrolides--therapeutic use<br/>Male<br/>Middle Aged<br/>Percutaneous Coronary Intervention<br/>Prospective Studies<br/>Sirolimus--analogs & derivatives